Gregory G Schwartz Selected Research

Gregory G Schwartz Research Topics

Disease

83	Acute Coronary Syndrome 10/2022 - 01/2001
44	Myocardial Infarction 10/2022 - 01/2002
24	Unstable Angina 10/2022 - 09/2002
24	Stroke (Strokes) 01/2021 - 01/2002
20	Coronary Disease (Coronary Heart Disease) 10/2022 - 07/2004
17	Ischemic Stroke 10/2022 - 11/2012
17	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2013
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2009
14	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017 - 01/2001
9	Heart Failure 01/2022 - 06/2011
9	Inflammation (Inflammations) 11/2019 - 09/2003
9	Insulin Resistance 01/2018 - 02/2010
8	Dyslipidemias (Dyslipidemia) 01/2022 - 09/2005
7	Atherosclerosis 01/2021 - 03/2013
7	Transient Ischemic Attack 10/2018 - 05/2011
7	Heart Arrest (Cardiac Arrest) 01/2017 - 01/2001
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 02/2017
5	Ischemia 01/2020 - 05/2003
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2019 - 04/2016
5	Atherosclerotic Plaque (Atheroma) 01/2018 - 09/2004
5	Hypertension (High Blood Pressure) 01/2018 - 10/2005
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013 - 10/2005
3	Atrial Fibrillation 01/2022 - 05/2011
3	Peripheral Arterial Disease 01/2022 - 01/2020
3	Thrombosis (Thrombus) 01/2020 - 06/2009
3	Prediabetic State (Prediabetes) 01/2020 - 07/2015
3	Obesity 01/2018 - 02/2010
3	Ventricular Fibrillation 01/2017 - 05/2003
3	Infarction (Infarctions) 05/2006 - 01/2001
2	Hemorrhagic Stroke 12/2019 - 09/2002
2	Diabetes Mellitus 01/2018 - 05/2017
2	Edema (Dropsy) 01/2018 - 04/2016
2	Weight Gain 01/2018 - 04/2016
2	Muscular Diseases (Myopathy) 09/2014 - 06/2011
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2021
1	Cognitive Dysfunction 01/2021

Drug/Important Bio-Agent (IBA)

49	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022 - 01/2001
31	alirocumabIBA 10/2022 - 11/2014
21	Atorvastatin (Lipitor)FDA Link 01/2022 - 01/2001
18	LDL CholesterolIBA 10/2022 - 01/2001
18	CholesterolIBA 12/2020 - 01/2001
16	oxidized low density lipoproteinIBA 10/2022 - 07/2004
15	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2019
12	Lipoproteins (Lipoprotein)IBA 08/2022 - 09/2012
11	Lipoprotein(a)IBA 01/2022 - 09/2004
10	HDL CholesterolIBA 01/2020 - 10/2005
9	Proprotein Convertase 9IBA 08/2022 - 11/2018
8	aleglitazarIBA 01/2020 - 09/2013
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020 - 05/2003
7	Insulin (Novolin)FDA Link 01/2021 - 02/2010
7	dalcetrapibIBA 01/2020 - 12/2009
6	apabetaloneIBA 01/2021 - 04/2018
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
6	HDL LipoproteinsIBA 12/2020 - 05/2005
6	LipidsIBA 04/2018 - 01/2002
6	Pioglitazone (Actos)FDA Link 01/2018 - 12/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2010
5	C-Reactive ProteinIBA 11/2019 - 09/2003
4	Pharmaceutical PreparationsIBA 01/2018 - 12/2014
4	2,4-thiazolidinedione (thiazolidinedione)IBA 12/2014 - 05/2003
3	ApolipoproteinsIBA 08/2022 - 11/2018
3	Rosuvastatin Calcium (Crestor)FDA Link 01/2022 - 07/2004
3	Monoclonal AntibodiesIBA 01/2022 - 11/2014
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2009
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014 - 09/2004
3	Secretory Phospholipases A2IBA 01/2014 - 02/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2013 - 09/2003
2	Apolipoproteins B (ApoB)IBA 08/2022 - 06/2009
2	Ezetimibe (Zetia)FDA Link 01/2022 - 01/2019
2	Cholesterol Ester Transfer ProteinsIBA 01/2020 - 10/2017
2	varespladibIBA 01/2019 - 01/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2018 - 06/2009
2	CER-001IBA 01/2018 - 02/2017
2	Adenosine Triphosphate (ATP)IBA 01/2017 - 06/2012
2	Triglycerides (Triacylglycerol)IBA 06/2015 - 10/2005
2	CreatinineIBA 09/2014 - 06/2011
2	Phosphotransferases (Kinase)IBA 09/2014 - 06/2011
2	Phospholipases (Phospholipase)IBA 11/2013 - 02/2012
2	SugarsIBA 03/2013 - 02/2010
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2013 - 10/2009
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2013 - 09/2003
2	Antigen-Antibody Complex (Immune Complex)IBA 06/2009 - 09/2004
2	Apolipoprotein B-100 (Apo B 100)IBA 06/2009 - 09/2004
2	1-penicillamyl-Leu(2)- oxytocinIBA 06/2009 - 09/2004
2	PPAR gammaIBA 03/2005 - 05/2003
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	evolocumabIBA 10/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	SodiumIBA 01/2021
1	SubtilisinIBA 01/2021
1	ALN-PCSIBA 01/2021

Therapy/Procedure

37	Therapeutics 08/2022 - 07/2004
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 05/2006
3	Patient Readmission 07/2004 - 01/2001
2	Subcutaneous Injections 01/2022 - 01/2021
2	Secondary Prevention 11/2019 - 12/2014
2	Percutaneous Coronary Intervention 01/2019 - 05/2006